Malotiate Tablets
Function and Efficacy
Pharmacological experiments have shown that malotiate can promote the synthesis of liver cell protein and has a protective effect on liver damage in experimental animals caused by carbon tetrachloride, ethionine and aminogalactose, thereby reducing liver cell necrosis and improving liver cell function.
Ingredients
The main ingredient of this product is: Malotiate. Its chemical name is: 1,3-dithioxo-2-ylidene-malonic acid diisopropyl ester. Molecular formula: C12H16O4S2. Molecular weight: 288.39.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| MalotilateIngredients |
It promotes the synthesis of liver cell protein and has a protective effect on the liver damage of experimental animals caused by carbon tetrachloride, ethionine and aminogalactose, thereby reducing liver cell necrosis and improving liver cell function. More |
59937-28-9 | 4 |
Appearance
This product is a film-coated tablet, which appears light yellow after removing the film coating.
Indication
It is suitable for chronic hepatitis, cirrhosis, liver damage caused by advanced schistosomiasis and hypoproteinemia complicated by pulmonary tuberculosis.
Usage and Dosage
Oral administration. 0.6g per day, 0.4g for those weighing less than 50kg, divided into 3 doses after meals
Adverse Reactions
A few people experience loss of appetite, nausea, vomiting, dizziness, and occasionally rash or itchy skin.
Precautions
It is contraindicated for use in children, pregnant women, lactating women and those who are allergic to this product.
Special Population Medication
Precautions for children: Not for use in children. Precautions for pregnancy and lactation: Not for use in pregnant and lactating women. Precautions for the elderly: Not yet clear.
Drug Interactions
Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.
Storage
Keep away from light and store in a sealed container.
Packaging Specification
0.1g
Validity Period
24 months